Moreover, Lian and colleagues showed that miR-23a expression was higher in glioma tissues of 79 samples than in the matched adjacent tissues, consistent with our findings, and that inhibition of miR-23a could suppress glioma cell growth via targeting apoptotic protease activating factor-1 (APAF1)12. This evidence concerns the gene APAF1 and central nervous system cancer.